Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer

被引：0
|
作者：
Weiwei Feng
Nan Jia
Haining Jiao
Jun Chen
Yan Chen
Yueru Zhang
Menghan Zhu
Chongying Zhu
Lifei Shen
Wenqing Long
机构：
[1] Ruijin Hospital,Department of Gynecology and Obstetrics
[2] Shanghai Jiaotong University School of Medicine,undefined
[3] Department of Gynecology,undefined
[4] Obstetrics and Gynecology Hospital of Fudan University,undefined
[5] Shanghai Gemple Biotech Co.,undefined
[6] Ltd.,undefined
来源：
Journal of Translational Medicine | / 19卷
关键词：
Circulating tumor DNA; High-risk; endometrial cancer; Recurrence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Clinical Validity of Circulating Tumor DNA as Prognostic and Predictive Marker for Personalized Colorectal Cancer Patient Management
    Hallermayr, Ariane
    Steinke-Lange, Verena
    Vogelsang, Holger
    Rentsch, Markus
    de Wit, Maike
    Haberl, Christopher
    Holinski-Feder, Elke
    Pickl, Julia M. A.
    CANCERS, 2022, 14 (03)
  • [42] Plasma circulating tumor DNA as a molecular marker for oral cancer
    Paramasivam, Arumugam
    ORAL ONCOLOGY, 2022, 130
  • [43] Free Circulating Tumor DNA as a Diagnostic Marker for Breast Cancer
    Hashad, D.
    Sorour, A.
    Ghazal, A.
    Talaat, I.
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2012, 26 (06) : 467 - 472
  • [44] Tumor-specific DNA methylation in high-risk prostate cancer
    Litovkin, K.
    Lerut, E.
    Joniau, S.
    Geveart, O.
    Isebaert, S.
    Spahn, M.
    Kneitz, B.
    Haustermans, K.
    van Eynde, A.
    Bollen, M.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S35 - S35
  • [45] Circulating tumor DNA as a marker of recurrence risk in stage III colorectal cancer: The α-CORRECT study
    Schoen, Robert E.
    Diergaarde, Brenda
    Young, Gregory
    Hall, David W.
    Marti, Tara
    Mazloom, Amin
    Costa, Gina
    Subramaniam, Somasundaram
    Palomares, Melanie R.
    Garces, Jorge
    Baehner, Frederick
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 302 - 302
  • [46] Circulating tumor DNA (ctDNA) as a marker of recurrence risk in stage II colon cancer (CC).
    Tie, Jeanne
    Kinde, Isaac
    Wang, Yuxuan
    Wong, Hui-li
    Skinner, Iain
    Wong, Rachel
    Steel, Malcolm
    Diaz, Luis A.
    Papadopoulos, Nickolas
    Kosmider, Suzanne
    Yip, Desmond
    Underhill, Craig
    Haydon, Andrew Mark
    Christie, Michael
    Strausberg, Robert
    Kinzler, Kenneth W.
    Vogelstein, Bert
    Gibbs, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [47] Circulating Tumor DNA as a Marker of Recurrence Risk in Stage III Colorectal Cancer: The α-CORRECT Study
    Diergaarde, Brenda
    Young, Greg
    Hall, David W.
    Mazloom, Amin
    Costa, Gina L.
    Subramaniam, Soma
    Palomares, Melanie R.
    Garces, Jorge
    Baehner, Frederick L.
    Schoen, Robert E.
    xact Sciences MRD Group
    JOURNAL OF SURGICAL ONCOLOGY, 2025,
  • [48] Circulating tumor DNA mutation as a prognostic marker in melanoma with brain metastasis.
    Behera, Tapas Ranjan
    Song, Jung Min
    Eicher, Donald Matthew
    Gastman, Brian
    Farkas, Daniel H.
    Funchain, Pauline
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [49] Establishment of Patient-Derived Tumor Xenograft Models of High-Risk Endometrial Cancer
    Zhu, Menghan
    Jia, Nan
    Nie, Yanyan
    Chen, Jun
    Jiang, Yahui
    Lv, Tianjiao
    Li, Yuanyuan
    Yao, Liangqing
    Feng, Weiwei
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (09) : 1812 - 1820
  • [50] Circulating tumor DNA as versatile tumor marker in the treatment of pan-cancer
    Nishizuka, Satoshi
    CANCER SCIENCE, 2022, 113
12345